WASHINGTON — FDA Commissioner Robert Califf needs non-public insurers to chip in on doing post-approval medical analysis on medicine. It’s a brand new request from the company chief, who’s lengthy pushed to seek out new methods to check medicine.
“I’m not conscious of a serious effort by the insurance policy to assist individuals get research carried out,” he mentioned at America’s Well being Insurance coverage Plans convention on Thursday. “In reality, what I’m listening to from clinicians out there’s simply the alternative, that it’s very exhausting to do analysis within the present setting.”
Unlock this text by subscribing to STAT+ and luxuriate in your first 30 days free!
